Our science advisory board member, Dr. Tom Bumol believes that to develop a robust disease model, you need to map every outcome - successes, failures, and surprises - along the drug development journey. See his recent interview with our Chief Scientist, Shai Shen-Orr: www.cytoreason.com/podcast/